)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Entera Bio
Entera Bio (ENTX) investor relations material
Entera Bio Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary3 Jun, 2026
Voting matters and shareholder proposals
Election of three Class III directors to serve until the 2029 Annual Meeting.
Approval of amended compensation terms for non-executive directors.
Approval of share-based compensation for two directors and the Chairman.
Approval of one-time compensation grants for two directors, including the CEO.
Amendment to the 2018 Equity Incentive Plan to increase shares issuable by 2,500,000.
Amendment to the Articles of Association to increase authorized share capital.
Advisory, non-binding vote on executive officer compensation.
Appointment of PwC as independent auditors for fiscal year ending December 31, 2026, with authorization to set auditor compensation.
Board of directors and corporate governance
Board recommends a vote in favor of all ten proposals.
Annual meeting scheduled for July 14, 2026, in Jerusalem, Israel.
Executive compensation and say-on-pay
Proposals include approval of amended and one-time compensation for directors and CEO.
Advisory vote on executive compensation, including tables and narrative discussion.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Entera Bio
- Proxy covers director elections, compensation, equity plan, capital structure, and auditor approval.ENTX
Proxy filing3 Jun 2026 - Annual meeting covers director elections, compensation, equity plan, and capital increase proposals.ENTXProxy filing14 May 2026
- Net loss rose to $3.5M in Q1 2026; cash increased to $20.4M, but more funding is needed.ENTXQ1 20268 May 2026
- Oral peptide therapy innovator advances late-stage pipeline, bolstered by $10M private placement.ENTXRegistration filing8 May 2026
- Oral anabolic EB613 could transform osteoporosis care by improving access and adherence.ENTXKOL event20 Apr 2026
- FDA-aligned EB613 Phase 3, pipeline advanced, net loss $11.4M, cash supports into Q3 2026.ENTXQ4 202527 Mar 2026
- Oral peptide platform delivers first-in-class osteoporosis therapy with strong clinical results.ENTXCorporate presentation23 Mar 2026
- EB613, an oral osteoporosis therapy, nears phase three as regulatory changes may expedite approval.ENTXOppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 202524 Dec 2025
- Up to $100M in securities registered to fund oral peptide therapy, with at-the-market sales via Leerink Partners.ENTXRegistration Filing16 Dec 2025
Next Entera Bio earnings date
Q2 20267 Aug, 2026
Entera Bio
Next Entera Bio earnings date
Q2 20267 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage